XC Fees and Costs — WisdomTree True Emerging Markets Fund
Data updated: 2026-09-14
The net expense ratio is 0.32%. There are no sales loads or redemption fees. In fiscal 2026 the fund paid $155K in broker commissions, 0.1724% of average net assets, and portfolio turnover was 11%.
XC Fees and Expenses
Annual operating expenses and sales charges of XC. Prospectus, as of June 30, 2025.
| Annual operating expenses | |
|---|---|
| Management fee | 0.32% |
| 12b-1 fee | 0.00% |
| Other expenses | 0.00% |
| Gross expense ratio | 0.32% |
| Fee waiver | — |
| Net expense ratio | 0.32% |
| Sales charges | |
|---|---|
| Max front load | — |
| Max deferred load | — |
| Redemption fee | — |
| Expense limitation in place (N-CEN) | Yes |
| Fees waived or reduced during the year | Yes |
| Waived fees subject to recoupment | No |
XC Costs Over Time
On $10,000 invested in XC, assuming 5% a year before costs, total costs come to $311 over 5 years, cutting the return by 0.52% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).
| $10,000 invested | Sell after 1 year | Sell after 3 years | Sell after 5 years |
|---|---|---|---|
| Value before costs | $10,500 | $11,576 | $12,763 |
| Fund expenses (net expense ratio 0.32%) | $34 | $105 | $184 |
| Trading costs (broker commissions) | $18 | $57 | $99 |
| Lost growth on money paid in costs | $0 | $8 | $28 |
| Total costs | $52 | $170 | $311 |
| Value after costs | $10,448 | $11,406 | $12,452 |
| Impact on return, per year | 0.52% | 0.52% | 0.52% |
XC Trading Costs
Brokerage costs reported on SEC Form N-CEN for the fiscal year ending June 30, 2026.
- Explicit cost rate (commissions ÷ average net assets): 0.1724%
- Total broker commissions: $155K
- Bought from dealers (principal trades, not a cost): $18.0M
- Portfolio turnover (prospectus): 11%
- Securities on loan, average value: $1.2M
- Net income from securities lending: $34K (0.038% of average net assets)
XC Agency Brokers
Commissions paid.
| Broker | Amount | Share |
|---|---|---|
| HSBC SECURITIES (USA) INC. | $40K | 25.73% |
| BOFA SECURITIES, INC. | $35K | 22.72% |
| J.P. Morgan Securities LLC | $32K | 20.98% |
| CLSA AMERICAS, LLC | $26K | 16.98% |
| GOLDMAN SACHS & CO. LLC | $16K | 10.54% |
| MORGAN STANLEY & CO. LLC | $4K | 2.29% |
| CitiGroup Global Markets Inc. | $520 | 0.34% |
| UBS SECURITIES LLC | $374 | 0.24% |
| SANTANDER US CAPITAL MARKETS LLC | $175 | 0.11% |
| BARCLAYS CAPITAL, INC. | $111 | 0.07% |
XC Dealer Counterparties
Securities bought directly from dealers (principal trades).
| Broker | Amount | Share |
|---|---|---|
| J.P. Morgan Securities LLC | $17.8M | 98.96% |
| GOLDMAN SACHS & CO. LLC | $188K | 1.04% |
| ZYDUS LIFESCIENCES LIMITED | $574 | 0.00% |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.